Skip to main content
. 2016 Aug 15;11(8):e0160460. doi: 10.1371/journal.pone.0160460

Table 4. Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years after start of ART.

Cells/μL N (%) Unadjusted HR (95% CI) Adjusted HR (95% CI)*
CD4 count at start of ART (cells/μL) ≥350 4,296 (33%) 1 1
200–349 3,372 (26%) 1.09 (0.88, 1.35) 0.96 (0.77, 1.19)
100–199 2,120 (16%) 1.38 (1.09, 1.73) 0.94 (0.74, 1.20)
50–99 1,229 (9%) 1.60 (1.24, 2.08) 0.88 (0.67, 1.16)
0–49 1,994 (15%) 1.19 (0.94, 1.52) 0.69 (0.52, 0.90)
CD4 10 years after start of ART (cells/μL) ≥750 3,396 (26%) 1 1
500–749 4,093 (31%) 1.11 (0.85, 1.46) 1.04 (0.80, 1.37)
350–499 2,644 (20%) 1.72 (1.32, 2.25) 1.47 (1.12, 1.93)
200–349 1,850 (14%) 2.37 (1.81, 3.10) 1.92 (1.45, 2.54)
100–199 628 (5%) 4.28 (3.16, 5.78) 3.33 (2.42, 4.60)
0–99 400 (3%) 9.25 (6.90, 12.40) 6.85 (4.89, 9.60)

CI: Confidence interval

*Adjusted for sex, regimen, age (16–39, 40–49, 50–59, 60–69, ≥70 years), mode of transmission (IDU or not), HIV-1 RNA levels 10 years after start of ART (0–50, 51–1000, >1000 copies/ml), AIDS status and mutually adjusted for both CD4 measurements and stratified by cohort.